メリーランド州における結腸癌の臨床試験
メリーランド州内の拠点で、結腸癌に関する22件の研究が参加者を募集しています。
メリーランド州内の都市
公式研究テキスト（英語）
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Christiana Care - Union Hospital, Elkton
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第1相
18歳〜120歳 · 全性別 · 2026/10/02更新 · NCT06885697Family Communications After Genetic Testing
- Sinai Hospital of Baltimore, Baltimore
- Northwest Hospital Center, Randallstown
- UM Saint Joseph Medical Center, Towson
- 他1件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- University of Maryland ( Site 2016), Baltimore
- Greater Baltimore Medical Center ( Site 0068), Baltimore
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06997497Collection of Blood From Patients With Cancer
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/09/28更新 · NCT00034216Genomic Services Research Program
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
1 Month – 105 Years · 全性別 · 2026/09/28更新 · NCT02595957Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Greater Baltimore Medical Center, Baltimore
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Saint Agnes Hospital, Baltimore
- Cancer Center For Blood Disorders A Division of American Oncology Partners P.A, Bethesda
- Sarah Cannon Research Institute Scri Oncology Partners, Brandywine
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- University of Maryland Greenbaum, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07058012Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Kaiser Permanente-Woodlawn Medical Center, Baltimore
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg
- Kaiser Permanente - Kensington Medical Center, Kensington
- 他2件
被験者募集中
45歳〜70歳 · 全性別 · 2026/09/02更新 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- UM Upper Chesapeake Hematology and Oncology - Aberdeen, Aberdeen
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- 他14件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05174169Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第1/2相
18歳〜72歳 · 全性別 · 2026/08/24更新 · NCT03190941KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/31更新 · NCT06411691EXoPERT EMERALD Clinical Study
- John Hopkins University, Baltimore
被験者募集中観察研究健康なボランティア歓迎
45歳以上 · 全性別 · 2026/07/01更新 · NCT07186296Integrated Cancer Repository for Cancer Research
- Northwest Hospital, Randallstown
- William E. Kahlert Regional Cancer Center, Westminster
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Maryland Oncology Hematology, Columbia
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07011576Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Advanced Molecular Imaging and Therapy, Glen Burnie
- United Theranostics - Chesapeake, Glen Burnie
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/11更新 · NCT05283330Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/06/05更新 · NCT00451022Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Johns Hopkins University, Baltimore
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT06040541Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Johns Hopkins University, Baltimore
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, Bethesda
被験者募集中第3相
18歳以上 · 全性別 · 2026/01/23更新 · NCT05855200SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- 他1件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。